Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining Contribution of Sex and Genetics to DHA Synthesis Rates Over 12 Weeks of EPA Supplementation in Healthy Individuals

NCT06975241 is registered in ClinicalTrials.gov with University of Toronto as lead sponsor.

NCT NCT06975241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06975241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining Contribution of Sex and Genetics to DHA Synthesis Rates Over 12 Weeks of EPA Supplementation in Healthy Individuals
Lead sponsor
University of Toronto
Phase
Phase 4
Overall status
Recruiting
Start date
July 29, 2025
Completion date
September 30, 2026
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, metabolism, lipids, omega 3